Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 11/20 | 0.56 |
| ▸ | DRD3 | P35462 | 9/20 | 0.56 |
| ▸ | DRD4 | P21917 | 4/20 | 0.56 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | HTR1D | P28221 | 1/20 | 0.43 |
| ▸ | HTR1B | P28222 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7516458 | 1.00 | DRD2 (0.56) | DRD2DRD3DRD4ADRA1DADRA1A | |
| Hydrochloric Acid SCHEMBL7520024 | 0.99 | DRD2 (0.55) | DRD2DRD3DRD4ADRA1DADRA1A | |
| Hydrochloric Acid SCHEMBL7520028 | 0.99 | DRD2 (0.55) | DRD2DRD3DRD4ADRA1DADRA1A | |
| SCHEMBL8019711 | 0.88 | DRD2 (0.55) | DRD2DRD3DRD4HTR1DHTR1B | |
| Hydrochloric Acid SCHEMBL7335560 | 0.87 | DRD2 (0.54) | DRD2DRD3DRD4HTR1DHTR1B | |
| Hydrochloric Acid SCHEMBL7335562 | 0.87 | DRD2 (0.54) | DRD2DRD3DRD4HTR1DHTR1B | |
| Hydrochloric Acid SCHEMBL7932123 | 0.84 | DRD2 (0.51) | DRD2DRD3DRD4CA1CA2 | |
| Hydrochloric Acid SCHEMBL7932125 | 0.84 | DRD2 (0.51) | DRD2DRD3DRD4CA1CA2 | |
| SCHEMBL7933887 | 0.83 | DRD2 (0.69) | DRD2DRD3DRD4ADRA1DADRA1A | |
| SCHEMBL7933885 | 0.83 | DRD2 (0.69) | DRD2DRD3DRD4ADRA1DADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0970042-B1 | 5-HYDROXYMETHYL-2-AMINOTETRALINS AS CARDIOVASCULAR AGENTS | ZAMBON SPA (IT) | 2002-01-09 | — | — | EP | disclosed |
| US-6232348-B1 | AGONISTS OF THE DOPAMINERGIC RECEPTORS MORE POTENT THAN DOPAMINE AND OTHER KNOWN COMPOUNDS, DEPRIVED OF INTERACTION WITH OTHER RECEPTORS AND ORALLY BIOAVAILABLE WITH A LONG TERM OF ACTION | ZAMBON GROUP S.P.A. (IT) | 2001-05-15 | — | — | US | disclosed |
| US-6063964-A | 5-hydroxymethyl-2-aminotetralins as cardiovascular agents | ZAMBON GROUP S.P.A. (IT) | 2000-05-16 | — | — | US | disclosed |
| EP-0970042-A1 | 5-HYDROXYMETHYL-2-AMINOTETRALINS AS CARDIOVASCULAR AGENTS | ZAMBON GROUP S.p.A. (IT) | 2000-01-12 | — | — | EP | disclosed |
| EP-0966423-A1 | HYDROXYMETHYL DERIVATIVES OF 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE AS CARDIOVASCULAR AGENT | ZAMBON GROUP S.p.A. (IT) | 1999-12-29 | — | — | EP | disclosed |
| WO-1998038154-A1 | HYDROXYMETHYL DERIVATIVES OF 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE AS CARDIOVASCULAR AGENT | ZAMBON GROUP S.P.A. (IT) | 1998-09-03 | — | — | WO | disclosed |
| WO-1998038155-A1 | 5-HYDROXYMETHYL-2-AMINOTETRALINS AS CARDIOVASCULAR AGENTS | ZAMBON GROUP S.P.A. (IT) | 1998-09-03 | — | — | WO | disclosed |